Prospective observational study of treatment for primary Sjogren's syndrome-related interstitial lung disease

Prospective observational study of treatment for primary Sjogren's syndrome-related interstitial lung disease - Observational study of treatment for Sjogren's syndrome-related interstitial lung disease

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000020207

Enrollment

Registered

2016-01-12

Start date

2016-01-12

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Primary Sjogren&#39

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Fulfilling the diagnostic criteria of primary Sjogren's syndrome (Arthritis Care Res 2012;64:475-87) 2. Diagnosed as having interstitial lung disease on the basis of chest CT findings (bilateral reticulation and/or ground glass attenuation) and clinical assessment 3. Patient consent for treatment initiation

Exclusion criteria

Exclusion criteria: 1. Combined case with other collagen vascular diseases 2. Pregnancy or childbearing potential

Design outcomes

Primary

Measure	Time frame
Changes in pulmonary function after 1-year treatment	—

Secondary

Measure	Time frame
Treatment regimens Changes in chest CT findings, exercise torelance, and dyspnea scores after 1-year treatment Adverse events after treatment initiation	—

Countries

Japan

Contacts

Public ContactYasunori Enomoto

Hamamatsu University School of Medicine Second Division, Department of Internal Medicine

enomotoy@hama-med.ac.jp053-435-2263

Outcome results